Gozes I - Search Results

1

A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth.

Moody TW, Zia F, Draoui M, Brenneman DE, Fridkin M, Davidson A, Gozes I. Moody TW, et al. Among authors: gozes i. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4345-9. doi: 10.1073/pnas.90.10.4345. Proc Natl Acad Sci U S A. 1993. PMID: 8389448 Free PMC article.

2

A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model.

Gozes I, Fridkin M. Gozes I, et al. J Clin Invest. 1992 Sep;90(3):810-4. doi: 10.1172/JCI115955. J Clin Invest. 1992. PMID: 1522236 Free PMC article.

3

Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist.

Glowa JR, Panlilio LV, Brenneman DE, Gozes I, Fridkin M, Hill JM. Glowa JR, et al. Among authors: gozes i. Brain Res. 1992 Jan 20;570(1-2):49-53. doi: 10.1016/0006-8993(92)90562-n. Brain Res. 1992. PMID: 1617429

4

An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.

Gozes I, McCune SK, Jacobson L, Warren D, Moody TW, Fridkin M, Brenneman DE. Gozes I, et al. J Pharmacol Exp Ther. 1991 Jun;257(3):959-66. J Pharmacol Exp Ther. 1991. PMID: 1646331

5

A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes.

Gozes Y, Brenneman DE, Fridkin M, Asofsky R, Gozes I. Gozes Y, et al. Among authors: gozes i. Brain Res. 1991 Feb 1;540(1-2):319-21. doi: 10.1016/0006-8993(91)90528-4. Brain Res. 1991. PMID: 1647246

6

Spontaneous electrical activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cell cultures.

Agoston DV, Eiden LE, Brenneman DE, Gozes I. Agoston DV, et al. Among authors: gozes i. Brain Res Mol Brain Res. 1991 Jun;10(3):235-40. doi: 10.1016/0169-328x(91)90066-7. Brain Res Mol Brain Res. 1991. PMID: 1715967

7

Cytokine regulation of neuronal survival.

Brenneman DE, Schultzberg M, Bartfai T, Gozes I. Brenneman DE, et al. Among authors: gozes i. J Neurochem. 1992 Feb;58(2):454-60. doi: 10.1111/j.1471-4159.1992.tb09743.x. J Neurochem. 1992. PMID: 1729393

8

Acquired immune deficiency syndrome and the developing nervous system.

Brenneman DE, McCune SK, Gozes I. Brenneman DE, et al. Among authors: gozes i. Int Rev Neurobiol. 1990;32:305-53. doi: 10.1016/s0074-7742(08)60587-5. Int Rev Neurobiol. 1990. PMID: 1981886 Review. No abstract available.

9

Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat.

Hill JM, Gozes I, Hill JL, Fridkin M, Brenneman DE. Hill JM, et al. Among authors: gozes i. Peptides. 1991 Jan-Feb;12(1):187-92. doi: 10.1016/0196-9781(91)90186-s. Peptides. 1991. PMID: 2052494

10

Vasoactive intestinal peptide potentiates sexual behavior: inhibition by novel antagonist.

Gozes I, Meltzer E, Rubinrout S, Brenneman DE, Fridkin M. Gozes I, et al. Endocrinology. 1989 Dec;125(6):2945-9. doi: 10.1210/endo-125-6-2945. Endocrinology. 1989. PMID: 2583049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters